4//SEC Filing
Bancel Stephane 4
Accession 0001127602-25-007916
CIK 0001682852other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:27 PM ET
Size
9.5 KB
Accession
0001127602-25-007916
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Bancel Stephane
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-03-03$31.53/sh+57,493$1,812,754→ 9,210,686 total(indirect: See Footnote) - Purchase
Common Stock
2025-03-03$31.04/sh+102,821$3,191,564→ 9,153,193 total(indirect: See Footnote)
Holdings
- 5,493,897
Common Stock
- 6,564,880(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]The transactions reported in this Form 4 represent open market purchases of 160,314 shares of the Issuer's common stock, totaling $5,005,040, by Boston Biotech Ventures, LLC ("Boston Biotech Ventures"), of which the Reporting Person is the majority equity unit holder and the sole managing member.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.38 to $31.38. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
- [F3]These shares are owned directly by Boston Biotech Ventures. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $31.39 to $31.96. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
- [F5]These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001443340
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:27 PM ET
- Size
- 9.5 KB